Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy

Abstract Background and aims Prognostic biomarkers identifying patients with early tumor progression after local ablative therapy remain an unmet clinical need. The aim of this study was to investigate circulating miR-21 and miR-210 levels as prognostic biomarkers of HCC treated by CT-guided high-do...

Full description

Bibliographic Details
Main Authors: Matthias Stechele, Henrike Link, Heidrun Hirner-Eppeneder, Marianna Alunni-Fabbroni, Moritz Wildgruber, Lukas Salvermoser, Stefanie Corradini, Regina Schinner, Najib Ben Khaled, Daniel Rössler, Eithan Galun, Shraga Nahum Goldberg, Jens Ricke, Philipp Maximilian Kazmierczak
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Radiation Oncology
Subjects:
microRNA
HCC
Interventional oncology
Biomarker
Online Access:https://doi.org/10.1186/s13014-023-02316-2

Internet

https://doi.org/10.1186/s13014-023-02316-2

Similar Items